reata pharmaceuticals stock forecast
According to 6 Wall Street analyst s that have issued a 1 year RETA price target the average RETA price target is 4383 with the highest RETA stock price forecast at 7300 and the lowest. Reata Pharmaceuticals stock price forecast.
Why Reata Pharmaceuticals Stock Moved Reta Stock Has Lost 11 Since 2017 Primarily Due To Unfavorable Change In Revenues Trefis
Reata Pharmaceuticals Inc.
. Reata Pharmaceuticals Stock Forecast Over the next 52 weeks Reata Pharmaceuticals has on average historically risen by 457 based on the past 5 years of stock performance. Reata Pharmaceuticals stock forecasts are. The lowest target is 2727 and.
According to 15 stock analysts the average 12-month stock price forecast for RETA stock is 5168 which predicts an increase of 8793. The Reata Pharmaceuticals Inc - Class A stock forecast is 12021680784196 USD for 2023 October 04 Wednesday. NASDAQRETA Get Ratings stock price gapped up before the market opened on Wednesday.
Target levels support and resistance levels. Reata Pharmaceuticals Stock Prediction. The businesss fifty day simple moving average is 2559 and its two-hundred day simple moving average is 2934.
Technical analysis historical chart. The Reata Pharmaceuticals stock prediction results are shown below and presented as a graph table and text information. Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs tables and text information divided into time intervals.
Reata Pharmaceuticals RETA is a clinical-stage biopharma company focused on developing small molecule therapies for life-threatening. In the short term 2weeks RETAs. The stock had previously closed at 2321 but.
The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 4300 with a high estimate of 7600 and a low estimate of 2700. RETA Stock Price Prediction. Shares of RETA opened at 2513 on Monday.
Reata Pharmaceuticals Stock Forecast for 2022. Reata Pharmaceuticals Stock Prediction. And 720478 USD for 2027 October 04 Monday with.
Reata Pharmaceuticals stock forecast for 2025 by month. REATA PHARMACEUTICALS INC CLASS A stock price forecast for further price development up to 1895 time horizon. 9598 Upside Based on 6 Wall Street analysts offering 12 month price targets for Reata Pharmaceuticals in the last 3 months.
RETA stock forecast Our latest prediction for Reata Pharmaceuticals Incs stock price was made on the June 22 2017 when the stock price was at 2926. The average price target is. Reata Pharmaceuticals Stock Prediction.
Reata Pharmaceuticals Stock Prediction. Reata Pharmaceuticals Stock Prediction. Reata Pharmaceuticals Stock Prediction.
1 day and price target of 2631 USD. Oct 4 2022 0858AM EDT.
Reta Share Price And News Reata Pharmaceuticals Inc Nasdaq
Reta Stock Forecast Price News Reata Pharmaceuticals
Reta Reta Stock News Reta Reata Stock Investors Sue Reata Pharmaceuticals Inc Reta Stocks Youtube
Reata Pharmaceuticals Inc 2021 Q2 Results Earnings Call Presentation Nasdaq Reta Seeking Alpha
Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S
Reata Pharmaceuticals Inc Our Science Our Technologies Hsp90 Modulators
Irving Biotech Reata Pharmaceuticals Sets Terms For Initial Public Offering Dallas Business Journal
Reta Stock News Today Reta Reta Stock Shareholders In Reata Pharmaceuticals Inc Class Action Youtube
Reata Pharmaceuticals Inc Reta Stock Price News Info The Motley Fool
Reata Pharmaceuticals Inc Reta Stock Price Us75615p1030 Marketscreener
Reata Pharmaceuticals Inc Trade Ideas Nasdaq Reta Tradingview
Reta Reata Pharmaceuticals Stock Price
What 5 Analyst Ratings Have To Say About Reata Pharmaceuticals Benzinga
Reta Stock Nosedives On Fda Panel S Rejection Of Kidney Drug Investor S Business Daily
Strong Insider Buying Could Indicate A Bottom In These 3 Stocks Nasdaq
Reata Pharmaceuticals Inc Reta Stock Price News Info The Motley Fool
Reata Pharmaceuticals Nasdaq Reta Reata Pharmaceuticals Earnings Preview Benzinga
Further Weakness As Reata Pharmaceuticals Nasdaq Reta Drops 6 9 This Week Taking One Year Losses To 80 Simply Wall St News
Why Reata Pharma Shares Are Trading Lower After Q2 Earnings Update